Skip to main content
. 2018 Sep 22;218(Suppl 2):S88–S98. doi: 10.1093/infdis/jiy420

Figure 2.

Figure 2.

Zostavax vaccination leads to an increase in circulating but not skin-resident varicella zoster virus (VZV)–specific T cells. Punch biopsy specimens (diameter, 5 mm) were taken from unchallenged skin before and after vaccination and immunohistological assessment was performed. A and B, Frequency of CD4+ (A) and CD8+ (B) T cells that expressed CD69. C and D, Representative immunostaining of CD4 (green) and Foxp3 (red; C) and cumulative data showing the frequency of Foxp3+ CD4+ T cells (D) in young and older individuals (before and after vaccination). E, Peripheral blood and skin-derived VZV-specific CD4+ T cells were enumerated by intracellular cytokine staining following overnight stimulation with VZV lysate (n = 6 for skin and n = 10 for blood). For panels A and B, data were assessed by the Mann-Whitney test. For panel D, data were assessed by 1-way analysis of variance with the Tukey post hoc test. For panel E, data were analyzed by the Wilcoxon paired test. Abbreviation: NS, not significant. *P < .05 and **P < .01.